As Hantavirus and Ebola Cases Rise, Long COVID Is Being Forgotten

Why It Matters

Ignoring Long COVID while celebrating the decline of COVID cases jeopardizes millions of disabled individuals and weakens preparedness for emerging pathogens.

Key Takeaways

• WHO reported 12,284 new COVID cases in April‑May 2026
• Long COVID clinics dropped from ~400 in 2022 to 26 in 2026
• Over 18 million people worldwide live with disabling Long COVID
• Hantavirus and Ebola outbreaks spark fear amid COVID fatigue
• Public health complacency hampers response to new infectious threats

Pulse Analysis

COVID‑19 may no longer dominate daily headlines, but the virus continues to generate new infections and long‑term disability. WHO data from April‑May 2026 show a modest rise in cases, and the term "post‑COVID" is misleading because millions still suffer from persistent symptoms. Long COVID, affecting an estimated 18 million people globally, is a chronic, often invisible condition that can impair cognition, energy, and overall quality of life. The shrinking network of specialized clinics—from roughly 400 in 2022 to just 26 today—highlights a funding gap that threatens timely diagnosis and treatment, especially in underserved regions.

At the same time, emerging threats like the Andes strain of hantavirus and a resurging Ebola outbreak in the Democratic Republic of Congo are capturing public attention. Social‑media amplification of these scares, coupled with pandemic fatigue, creates a paradox where newer diseases are feared more than a virus that still disables a sizable portion of the population. Misinformation spreads rapidly, and the politicization of public‑health measures erodes trust, making it harder to implement preventive actions such as vaccination, masking, and travel advisories. This dynamic underscores the need for consistent, science‑based communication to keep both COVID‑related and novel threats on the public agenda.

The convergence of dwindling Long COVID resources and rising complacency poses a systemic risk. Policymakers must prioritize sustained investment in chronic‑care infrastructure, expand telehealth options, and ensure equitable access to clinics across urban and rural areas. Simultaneously, reinforcing basic preventive practices—vaccination updates, mask usage in high‑risk settings, and rapid response to outbreak alerts—can mitigate the impact of both COVID‑19 and emerging pathogens. By treating Long COVID as a permanent public‑health challenge rather than a relic of the past, the United States can preserve hard‑won lessons from the pandemic and bolster resilience against future disease waves.